| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner
1 company
Marshall Randall is a Former 10% Owner at Protara Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 23 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 3,833 | $26.33 | $100,909.86 | -0.2% | |
| Jul 28, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 25,935 | $30.48 | $790,611.82 | -0.5% | |
| Jul 24, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 2,343 | $26.53 | $62,168.97 | -0.1% | |
| Jul 22, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 1,595 | $26.71 | $42,598.19 | - | |
| Jul 20, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 4,330 | $26.79 | $116,009.52 | -0.2% | |
| Jul 13, 2020 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 4,804 | $27.28 | $131,077.04 | -0.4% |